Carbarsone
Drug profile
Also known as: amebarsene, amebarsone, aminarson, arsambide, carbarson, fenarsone, leucarsone, p-Ureidobenzenearsonic acid, pentarsone
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Carbarsone is a drug catalogued in DrugCentral. Recorded indications include Acute amebiasis.
- Indications: Acute amebiasis.
- Molecular formula: C7H9AsN2O4; molecular weight 260.08 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Acute amebiasis
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Carbarsone is on its molecule page.
| Molecular formula | C7H9AsN2O4 |
|---|---|
| Molecular weight | 260.08 g/mol |
| CAS number | — |
| InChIKey | WWXBHTZSYYGCSG-UHFFFAOYSA-N |
| PubChem CID | 8480 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Carbarsone used for?
DrugCentral lists the following indications for Carbarsone: Acute amebiasis.
What is the chemical formula of Carbarsone?
Carbarsone has the molecular formula C7H9AsN2O4 and a molecular weight of 260.08 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3065 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1331366 — compound record and bioactivity
- PubChem CID 8480 — chemical identifiers
- DrugBank DB11382 — drug record
- FDA UNII 8PK70TXE1T — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.